BioCentury
ARTICLE | Company News

Oxagen, Oxford University deal

October 22, 2001 7:00 AM UTC

Oxagen received an exclusive license to the university's patents covering gene polymorphisms in asthma, psoriasis, inflammatory bowel disease and autoimmune thyroid disease. One patent, Oxagen said, c...